NCT02688374 A Bioequivalence Study of Three, 2 mg Nicotine Chewing Gums (Two Tests and One Reference) in Healthy Adult Smokers Status COMPLETED Phase PHASE1
NCT02688361 A Bioequivalence Study of an Acetylcysteine 2% Oral Solution Versus a Reference Fluimucil 2% Oral Solution Status COMPLETED Phase PHASE1
NCT02686424 Tumor Markers Study in Gastric Cancer for Cancer Immunotherapy (ONCO-RD 010 CRT) Status SUSPENDED Phase N/A
NCT02683785 A Study to Investigate the Efficacy and Safety of GSK3196165 in Inflammatory Hand Osteoarthritis Status COMPLETED Phase PHASE2
NCT02683746 Safety and Efficacy Study of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT02678234 An Efficacy and Safety Study of Theraflu Day Powder as Oral Solution for Cold and Flu Status WITHDRAWN Phase PHASE3
NCT02676895 A Study of the Safety and Immune Response of 2 Doses of a New Shigella Vaccine in Kenyan Adults Status COMPLETED Phase PHASE2
NCT02674581 A Study of the Pharmacokinetics and Safety of BMS-663068 Administered in Subjects With Normal Renal Function and With Mild, Moderate, Severe and End Stage Renal Dysfunction (ESRD) Status COMPLETED Phase PHASE1
NCT02673619 A Study to Evaluate Clinical Effect, Pharmacokinetics , Safety, and Tolerability of Umeclidinium in Palmar Hyperhidrosis Subjects Status COMPLETED Phase PHASE2
NCT02671188 A Study to Evaluate the Safety, Mode of Action and Clinical Efficacy of GSK3050002 in Subjects With Psoriatic Arthritis Status WITHDRAWN Phase PHASE1
NCT02666287 GSK961081 Alone and With Fluticasone Furoate (FF), Phase 1 (Ph1), Single Dose Regimen (SD), Repeat Dose Regimen (RD), Pharmacokinetic (PK) Study in Healthy Volunteer (HV) Status COMPLETED Phase PHASE1
NCT02666053 A Study to Assess the Effect of High Fat Meal and Increased Gastric pH on the Bioavailability of an Extended Release Formulation of BMS-663068 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02666001 A Study to Assess the Drug-drug Interaction of BMS 663068 With Methadone and Also With Buprenorphine/Naloxone Status COMPLETED Phase PHASE1
NCT02663102 Evaluation of Safety of GlaxoSmithKline (GSK) Vaccines' Quadrivalent Seasonal Influenza Vaccine, Fluarix Tetra When Administered According to the Approved Prescribing Information (PI) in Korea. Status COMPLETED Phase N/A
NCT02663089 A Phase 1 (Ph1), Single Dose (SD), GSK961081 Absorption, Distribution, Metabolism, and Excretion (ADME) Study in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02660736 Bioequivalence Study of Two Albiglutide Drug Products in Healthy Adult Subjects Status COMPLETED Phase PHASE1
NCT02658435 Assessment of Any Potential Retinal Effects of Tafenoquine (TQ) Status COMPLETED Phase PHASE1
NCT02658422 Bioequivalence of GW483100 10 Milligram (mg) Tablets in Healthy Subjects Under Fasting Conditions Status COMPLETED Phase PHASE1
NCT02654145 Omalizumab to Mepolizumab Switch Study in Severe Eosinophilic Asthma Patients Status COMPLETED Phase PHASE4
NCT02651467 A Study to Investigate Efficacy of Two Experimental Oral Rinses in Providing Long Term Relief From Pain Derived From Exposed Dentine in Response to Chemical, Thermal, Tactile, or Osmotic Stimuli. Status COMPLETED Phase NA